Synthesis and In Vivo Antiarrhythmic Activity Evaluation of Novel Scutellarein Analogues as Voltage-Gated Nav1.5 and Cav1.2 Channels Blockers
Molecules · 2023
DOI: 10.3390/molecules28217417 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2023. Verfasst von Wei Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of External Drug Delivery System and Preparation Technology in Universities of Yunnan, Yunnan University of Chinese Medicine, Kunming …. Hauptthemen laut MEDLINE: Aconitine, Anti-Arrhythmia Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Bioactive Ethnopharmacol Molecules Chemical Conversion and Application Innovation Team of the Department of Education of the Yunnan Province, Yunnan Provincial Key Laboratory of Molecular Biology for Sinomedicine.
Abstract (Originalsprache)
Malignant cardiac arrhythmias with high morbidity and mortality have posed a significant threat to our human health. Scutellarein, a metabolite of Scutellarin which is isolated from Scutellaria altissima L., presents excellent therapeutic effects on cardiovascular diseases and could further be metabolized into methylated forms. A series of 22 new scutellarein derivatives with hydroxyl-substitution based on the scutellarin metabolite in vivo was designed, synthesized via the conjugation of the scutellarein scaffold with pharmacophores of FDA-approved antiarrhythmic medications and evaluated for their antiarrhythmic activity through the analyzation of the rat number of arrhythmia recovery, corresponding to the recovery time and maintenance time in the rat model of barium chloride-induced arrhythmia, as well as the cumulative dosage of aconitine required to induce VP, VT, VF and CA in the rat model of aconitine-induced arrhythmia. All designed compounds could shorten the time of the arrhythmia continuum induced by barium chloride, indicating that 4′-hydroxy substituents of scutellarein had rapid-onset antiarrhythmic effects. In addition, nearly all of the compounds could normalize the HR, RR, QRS, QT and QTc interval, as well as the P/T waves’ amplitude. The most promising compound 10e showed the best antiarrhythmic activity with long-term efficacy and extremely low cytotoxicity, better than the positive control scutellarein. This result was also approved by the computational docking simulation. Most importantly, patch clamp measurements on Nav1.5 and Cav1.2 channels indicated that compound 10e was able to reduce the INa and ICa in a concentration-dependent manner and left-shifted the inactivation curve of Nav1.5. Taken together, all compounds were considered to be antiarrhythmic. Compound 10e even showed no proarrhythmic effect and could be classified as Ib Vaughan Williams antiarrhythmic agents. What is more, compound 10e did not block the hERG potassium channel which highly associated with cardiotoxicity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of External Drug Delivery System and Preparation Technology in Universities of Yunnan, Yunnan University of Chinese Medicine, Kunming 650500, China.
- Faculty of Chinese Materia Medica, Yunnan University of Chinese Medicine, Kunming 650500, China.
- Department of Anatomy and Histology, Shenzhen University Medical School, Shenzhen 518060, China.
- School of Food and Drug, Shenzhen Polytechnic, Shenzhen 518000, China.
- State Key Laboratory of Chemical Biology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China.
- Drug Discovery and Department of Applied Biology, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR, China.
ORCID-Profile: Yunshu Ma, Wenbin Jin
Förderung
- National Natural Science Foundation of China
- Bioactive Ethnopharmacol Molecules Chemical Conversion and Application Innovation Team of the Department of Education of the Yunnan Province
- Yunnan Provincial Key Laboratory of Molecular Biology for Sinomedicine
- Yunnan Provincial Joint Project of Traditional Chinese Medicine
- Natural Science Foundation of Yunnan
Zitieren
APA
Yang, W., Wang, W., Cai, S., Li, P., Zhang, D., Ning, J., Ke, J., Hou, A., Chen, L., Ma, Y., & Jin, W. (2023). Synthesis and In Vivo Antiarrhythmic Activity Evaluation of Novel Scutellarein Analogues as Voltage-Gated Nav1.5 and Cav1.2 Channels Blockers. Molecules. https://doi.org/10.3390/molecules28217417
Vancouver
Yang W, Wang W, Cai S, Li P, Zhang D, Ning J, et al. Synthesis and In Vivo Antiarrhythmic Activity Evaluation of Novel Scutellarein Analogues as Voltage-Gated Nav1.5 and Cav1.2 Channels Blockers. Molecules. 2023. doi:10.3390/molecules28217417
BibTeX
@article{Yang2023,
author = {Yang, Wei and Wang, Wenping and Cai, Song and Li, Peng and Zhang, Die and Ning, Jinhua and Ke, Jin and Hou, Anguo and Chen, Linyun and Ma, Yunshu and Jin, Wenbin},
title = {Synthesis and In Vivo Antiarrhythmic Activity Evaluation of Novel Scutellarein Analogues as Voltage-Gated Nav1.5 and Cav1.2 Channels Blockers},
journal = {Molecules},
year = {2023},
doi = {10.3390/molecules28217417}
}
EUVIMED